Health
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
By Marcus Chen
Wired
Moderna’s cancer vaccine is ‘likely’ to get approved. Skeptics question if it will be the best option.
The first Phase 3 data for a custom cancer vaccine has raised questions about whether the potential new treatment is needed.
Up nextNew mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 PercentHealth · 1 min read
More Health stories
Health
Disease outbreak impacts hunting in North Dakota’s southwestern units
By Marcus Chen
The Forum of Fargo-Moorhead
Technology
AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit
By Katherine Langford
MarketWatch
Business
My husband wants to sell our $1.5 million home and invest the proceeds. But this is where we raised our kids — and I can’t bear to leave.
By Katherine Langford
MarketWatch